简介：
Overview
This article presents a method for isolating and culturing human mesenchymal stromal cells (hMSCs) using autologous serum and fibrin clots. The approach minimizes risks associated with xenogeneic materials and enhances the clinical application of hMSC therapies in regenerative medicine.
Key Study Components
Area of Science
- Regenerative Medicine
- Tissue Engineering
- Cell Therapy
Background
- Human mesenchymal stromal cells (hMSCs) are crucial for regenerative therapies.
- Using autologous serum reduces rejection risks.
- Fibrin clots serve as effective scaffolds for cell delivery.
- This method aims to enhance clinical translation of hMSC therapies.
Purpose of Study
- To isolate and culture hMSCs in an autologous environment.
- To demonstrate a procedure that minimizes infection and inflammatory risks.
- To facilitate the use of hMSCs in orthopedic applications.
Methods Used
- Bone marrow collection and plasma isolation from patients.
- Preparation of autologous fibrin clots for cell delivery.
- Centrifugation and filtration techniques to isolate mononuclear cells.
- Cell culture and viability assays to assess hMSC growth.
Main Results
- Successful isolation and culture of hMSCs using patient-derived materials.
- Demonstrated viability and proliferation of hMSCs in autologous conditions.
- Establishment of a reliable method for preparing hMSC fibrin clot constructs.
Conclusions
- The autologous approach significantly reduces risks associated with cell therapies.
- Fibrin clots provide an effective means for surgical implantation of hMSCs.
- This method supports the advancement of hMSC applications in regenerative medicine.
What are mesenchymal stromal cells?
Mesenchymal stromal cells (MSCs) are multipotent stem cells that can differentiate into various cell types and are used in regenerative medicine.
Why use autologous serum?
Autologous serum reduces the risk of immune rejection and other complications associated with foreign materials.
What is the role of fibrin in this method?
Fibrin acts as a scaffold for cell delivery, facilitating easier handling and implantation of hMSCs.
How are hMSCs cultured in this study?
hMSCs are cultured using a complete proliferation medium supplemented with autologous serum.
What are the clinical implications of this research?
This research supports the safe and effective use of hMSCs in clinical settings, particularly in orthopedic applications.
繁體中文
